Fred Hutchinson Cancer Center is a premier cancer research and treatment organization dedicated to eliminating cancer and related diseases.
Subscribe to see Fred Hutchinson Cancer Center’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Fred Hutchinson Cancer Center is a healthcare & biomedical research company headquartered in United States. Xcout tracks 10 named people at Fred Hutchinson Cancer Center, including Thomas J. Jr. Lynch (President and Director).
4 more named people on record for Fred Hutchinson Cancer Center, with roles, board committees and tenure — see the full roster →
A few of Fred Hutchinson Cancer Center's closest competitors — see the full list of competitors and alternatives →
Roswell Park Comprehensive Cancer Center is a medical institution located in Buffalo, New York, dedicated to eliminating cancer. It provides comprehensive cancer treatment and care, characterized by compassion and innovation, and has served its community for over 125 years.
Vanderbilt-Ingram Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center providing advanced cancer care, treatment, and scientific research.
King Hussein Cancer Foundation and Center is a leading specialized healthcare institution in Jordan dedicated to cancer treatment, research, and prevention.
National Jewish Health is a leading hospital dedicated to the treatment and research of respiratory, cardiac, immune, and related disorders.
Memorial Sloan Kettering Cancer Center is a specialized medical facility that provides cancer treatment, diagnosis, and care services for adults and children. It also conducts comprehensive biomedical research and offers educational and training programs for clinicians and scientists.
City of Hope is a nonprofit biomedical research and healthcare organization headquartered in Duarte, California, specializing in cancer treatment, diabetes research, and other serious diseases. It serves patients through hospitals and clinics while advancing translational research, developing therapies, and providing clinical trials.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.